MAPT and Alzheimer disease: Previous studies have shown that CIH may contribute to the pathological process of AD by influencing β‐amyloid metabolism, promoting Tau protein phosphorylation, reducing brain‐derived neurotrophic factor (BDNF) expression, and inducing neuronal apoptosis [20, 39, 40].